As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...

The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy and its treatments for type 2 diabetes may cause rare occurrences of a ...

More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...

Advert Previous studies linked the drug to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION) and, for the first time, a regulator has since confirmed the side ...

A European health authority has found that medications containing semaglutide—such as Ozempic, Wegovy, and Rybelsus—can ...

He was diagnosed with nonarteritic anterior ischemic optic neuropathy, or NAION, an irreversible and untreatable vision loss believed to be caused by lack of blood flow to the optic nerve.

The European Medicines Agency (EMA) has warned that popular weight-loss and diabetes drugs containing semaglutide — including ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

The deep learning system distinguishes IIH, NAION, and healthy eyes with 93.6% accuracy, aiding in resource-limited settings. The model reduces the need for invasive procedures by using a single ...

About The Study: The results of this cohort study suggest that semaglutide use was associated with an increased risk of nonarteritic anterior ischemic optic neuropathy in patients with ...